Heart Failure Clinical Trial

The Effect of the MedSentry System on Medication Adherence

Summary

The goal of this pilot study to evaluate the effect of the MedSentry system, a multi-faceted medication adherence device and reminder system, on medication adherence and clinical outcomes in heart-failure (HF) patients. We will also evaluate the usability and satisfaction derived from using this system.

We hypothesize that:

The use of the MedSentry system will improve medication adherence in patients with a discharge diagnosis of HF.
The improvement in adherence correlates with fewer hospitalizations and emergency department (ED) visits.
The improvement in adherence correlates with better health-related quality of life.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients who have successfully completed the Partners Connected Cardiac Care Program (CCCP)
Take at least 3 and no more than 10 different daily medications (including both prescription and non-prescription/over the counter medications) to treat Heart Failure (HF) and other comorbid disorders.
Take medications no more than 4 specified times each day (i.e. morning, afternoon, early evening, bedtime).
The patient must be able to open a pill bottle independently.
The patient must be able to sort and manage their own medications.
Hospitalization within the last 24 months.
Have a telephone or cell phone.
Live in the greater Boston area.
The patients must speak, read and write English.
The patients must not be either vision or hearing impaired (i.e., unable to hear an alarm similar to a clock alarm or oven alarm).
Patient must have an Massachusetts General Hospital (MGH) affiliated care provider.

Exclusion Criteria:

Dementia or other conditions precluding the participant from providing informed consent or from learning to use the MedSentry pillbox.
Home environment unsuitable for the MedSentry pillbox and other installed equipment.
Awaiting revascularization, cardiac resynchronization or heart transplant.
Patients with a coexisting terminal illness like cancer or Chronic Renal Failure (CRF) requiring dialysis.

Study is for people with:

Heart Failure

Estimated Enrollment:

26

Study ID:

NCT01814696

Recruitment Status:

Terminated

Sponsor:

Massachusetts General Hospital

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Massachusetts General Hospital
Boston Massachusetts, 02114, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

26

Study ID:

NCT01814696

Recruitment Status:

Terminated

Sponsor:


Massachusetts General Hospital

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider